{"title":"血管内线圈栓塞治疗脑中动脉瘤破裂的临床疗效。","authors":"Takao Koiso, Yoji Komatsu, Daisuke Watanabe, Hisayuki Hosoo, Masayuki Sato, Yoshiro Ito, Tomoji Takigawa, Mikito Hayakawa, Aiki Marushima, Wataro Tsuruta, Noriyuki Kato, Kazuya Uemura, Kensuke Suzuki, Akio Hyodo, Eichi Ishikawa, Yuji Matsumaru","doi":"10.5797/jnet.oa.2024-0054","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Middle cerebral artery (MCA) aneurysms are difficult to treat with coil embolization (CE) due to their location and shape, but the number of CE-treated MCA has gradually increased as treatment techniques have improved. However, the outcomes of CE for ruptured MCA aneurysms are poorly understood. This study aimed to evaluate the outcomes of CE for ruptured MCA aneurysms.</p><p><strong>Methods: </strong>We retrospectively analyzed the medical records of patients with aneurysmal subarachnoid hemorrhages (aSAH) that were treated with CE between 2013 and 2020, and compared the differences in outcomes depending on aneurysm location.</p><p><strong>Results: </strong>A total of 468 patients with aSAH were included: 39 patients had ruptured MCA aneurysms (group M), and 429 had ruptured aneurysms at other sites (group O). There were no significant differences between the background characteristics of the 2 groups. Also, there were no significant intergroup differences in occlusion status, the frequency of complications such as ischemia, hemorrhaging, rebleeding, retreatment, or the modified Rankin Scale score at discharge. However, intracerebral hemorrhage (ICH) removal was required significantly more frequently in group M than in group O (10.3% vs. 0.5%, p = 0.0006). By case-matching analysis, there were no significant differences in these outcomes. All MCA cases that needed removal had more than 36 ml of hematoma volume. Logistic regression analysis showed that the existence of ICH at onset was a poor prognostic factor for ruptured MCA aneurysms.</p><p><strong>Conclusion: </strong>CE for ruptured MCA aneurysms produced acceptable outcomes in selected cases. However, the indications for CE in patients with ICH should be carefully considered.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 12","pages":"313-320"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11658887/pdf/","citationCount":"0","resultStr":"{\"title\":\"Clinical Outcomes of Endovascular Coil Embolization for Ruptured Middle Cerebral Artery Aneurysms.\",\"authors\":\"Takao Koiso, Yoji Komatsu, Daisuke Watanabe, Hisayuki Hosoo, Masayuki Sato, Yoshiro Ito, Tomoji Takigawa, Mikito Hayakawa, Aiki Marushima, Wataro Tsuruta, Noriyuki Kato, Kazuya Uemura, Kensuke Suzuki, Akio Hyodo, Eichi Ishikawa, Yuji Matsumaru\",\"doi\":\"10.5797/jnet.oa.2024-0054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Middle cerebral artery (MCA) aneurysms are difficult to treat with coil embolization (CE) due to their location and shape, but the number of CE-treated MCA has gradually increased as treatment techniques have improved. However, the outcomes of CE for ruptured MCA aneurysms are poorly understood. This study aimed to evaluate the outcomes of CE for ruptured MCA aneurysms.</p><p><strong>Methods: </strong>We retrospectively analyzed the medical records of patients with aneurysmal subarachnoid hemorrhages (aSAH) that were treated with CE between 2013 and 2020, and compared the differences in outcomes depending on aneurysm location.</p><p><strong>Results: </strong>A total of 468 patients with aSAH were included: 39 patients had ruptured MCA aneurysms (group M), and 429 had ruptured aneurysms at other sites (group O). There were no significant differences between the background characteristics of the 2 groups. Also, there were no significant intergroup differences in occlusion status, the frequency of complications such as ischemia, hemorrhaging, rebleeding, retreatment, or the modified Rankin Scale score at discharge. However, intracerebral hemorrhage (ICH) removal was required significantly more frequently in group M than in group O (10.3% vs. 0.5%, p = 0.0006). By case-matching analysis, there were no significant differences in these outcomes. All MCA cases that needed removal had more than 36 ml of hematoma volume. Logistic regression analysis showed that the existence of ICH at onset was a poor prognostic factor for ruptured MCA aneurysms.</p><p><strong>Conclusion: </strong>CE for ruptured MCA aneurysms produced acceptable outcomes in selected cases. However, the indications for CE in patients with ICH should be carefully considered.</p>\",\"PeriodicalId\":73856,\"journal\":{\"name\":\"Journal of neuroendovascular therapy\",\"volume\":\"18 12\",\"pages\":\"313-320\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11658887/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of neuroendovascular therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5797/jnet.oa.2024-0054\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neuroendovascular therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5797/jnet.oa.2024-0054","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:大脑中动脉(MCA)动脉瘤由于其位置和形状的原因,难以用线圈栓塞(CE)治疗,但随着治疗技术的进步,经线圈栓塞治疗的MCA数量逐渐增加。然而,CE治疗破裂的MCA动脉瘤的结果尚不清楚。本研究旨在评估CE治疗MCA动脉瘤破裂的效果。方法:回顾性分析2013年至2020年接受CE治疗的动脉瘤性蛛网膜下腔出血(aSAH)患者的医疗记录,比较不同动脉瘤位置的预后差异。结果:共纳入468例aSAH患者,其中中动脉动脉瘤破裂39例(M组),其他部位动脉瘤破裂429例(O组),两组背景特征差异无统计学意义。此外,在闭塞状态、并发症(如缺血、出血、再出血、再治疗)的频率或出院时的改良兰金量表评分方面,组间无显著差异。然而,M组需要脑出血(ICH)切除的频率明显高于O组(10.3% vs. 0.5%, p = 0.0006)。通过病例匹配分析,这些结果没有显著差异。所有需要切除的MCA病例血肿体积均大于36ml。Logistic回归分析显示,颅内出血是中动脉动脉瘤破裂的不良预后因素。结论:在选定的病例中,CE治疗MCA动脉瘤破裂的结果是可以接受的。然而,脑出血患者的CE适应症应仔细考虑。
Clinical Outcomes of Endovascular Coil Embolization for Ruptured Middle Cerebral Artery Aneurysms.
Objective: Middle cerebral artery (MCA) aneurysms are difficult to treat with coil embolization (CE) due to their location and shape, but the number of CE-treated MCA has gradually increased as treatment techniques have improved. However, the outcomes of CE for ruptured MCA aneurysms are poorly understood. This study aimed to evaluate the outcomes of CE for ruptured MCA aneurysms.
Methods: We retrospectively analyzed the medical records of patients with aneurysmal subarachnoid hemorrhages (aSAH) that were treated with CE between 2013 and 2020, and compared the differences in outcomes depending on aneurysm location.
Results: A total of 468 patients with aSAH were included: 39 patients had ruptured MCA aneurysms (group M), and 429 had ruptured aneurysms at other sites (group O). There were no significant differences between the background characteristics of the 2 groups. Also, there were no significant intergroup differences in occlusion status, the frequency of complications such as ischemia, hemorrhaging, rebleeding, retreatment, or the modified Rankin Scale score at discharge. However, intracerebral hemorrhage (ICH) removal was required significantly more frequently in group M than in group O (10.3% vs. 0.5%, p = 0.0006). By case-matching analysis, there were no significant differences in these outcomes. All MCA cases that needed removal had more than 36 ml of hematoma volume. Logistic regression analysis showed that the existence of ICH at onset was a poor prognostic factor for ruptured MCA aneurysms.
Conclusion: CE for ruptured MCA aneurysms produced acceptable outcomes in selected cases. However, the indications for CE in patients with ICH should be carefully considered.